Massachusetts Financial Services
ASND icon

Massachusetts Financial Services’s Ascendis Pharma A/S ASND Stock Holding History

Massachusetts Financial Services’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500M Buy
1,875,301
+14,632
+0.8% +$3.42M 0.16% 149
2026
Q1 		$426M Sell
1,860,669
-25,724
-1% -$5.77M 0.14% 151
2025
Q4 		$402M Buy
1,886,393
+3,612
+0.2% +$746K 0.13% 162
2025
Q3 		$374M Sell
1,882,781
-19,062
-1% -$3.56M 0.12% 183
2025
Q2 		$328M Buy
1,901,843
+23,926
+1% +$3.9M 0.1% 196
2025
Q1 		$293M Buy
1,877,917
+10,366
+0.6% +$1.48M 0.1% 211
2024
Q4 		$257M Buy
1,867,551
+565
+0% +$74.3K 0.08% 234
2024
Q3 		$279M Buy
1,866,986
+155,971
+9% +$21.1M 0.08% 225
2024
Q2 		$233M Buy
1,711,015
+93,185
+6% +$12.7M 0.07% 235
2024
Q1 		$245M Buy
1,617,830
+98,611
+6% +$14.1M 0.07% 237
2023
Q4 		$191M Buy
1,519,219
+254,749
+20% +$25.4M 0.06% 265
2023
Q3 		$118M Buy
1,264,470
+176,948
+16% +$16.6M 0.04% 336
2023
Q2 		$97.1M Sell
1,087,522
-270,052
-20% -$23.5M 0.03% 365
2023
Q1 		$146M Buy
1,357,574
+13,972
+1% +$1.6M 0.05% 295
2022
Q4 		$164M Buy
1,343,602
+159,246
+13% +$18.5M 0.06% 264
2022
Q3 		$122M Buy
1,184,356
+349,157
+42% +$33.1M 0.05% 301
2022
Q2 		$77.6M Buy
835,199
+64,270
+8% +$6.06M 0.03% 390
2022
Q1 		$90.5M Buy
770,929
+18,627
+2% +$2.16M 0.03% 401
2021
Q4 		$101M Buy
752,302
+8,323
+1% +$1.24M 0.03% 397
2021
Q3 		$119M Buy
743,979
+43,541
+6% +$5.96M 0.03% 362
2021
Q2 		$92.1M Sell
700,438
-10,607
-1% -$1.41M 0.03% 410
2021
Q1 		$91.6M Buy
711,045
+12,104
+2% +$1.84M 0.03% 390
2020
Q4 		$117M Buy
698,941
+33,184
+5% +$5.49M 0.04% 343
2020
Q3 		$103M Buy
+665,757
New +$95.7M 0.04% 321

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services's ASND Position: Q2 2026 in Review

Massachusetts Financial Services increased its Ascendis Pharma A/S (ASND) stake by 0.79% in Q2 2026, buying an estimated $3.42M and bringing the position to 1,875,301 shares worth $500M. The position accounts for 0.16% of the portfolio, ranked #149.

Massachusetts Financial Services first reported a position in ASND in Q3 2020 and has held it in 24 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Massachusetts Financial Services held 1,875,301 shares of Ascendis Pharma A/S worth $500M as of Q2 2026.
  • Massachusetts Financial Services bought 14,632 Ascendis Pharma A/S shares in Q2 2026, an estimated $3.42M.
  • Ascendis Pharma A/S made up 0.16% of Massachusetts Financial Services's portfolio in Q2 2026, its #149 holding.
  • Massachusetts Financial Services first reported a position in Ascendis Pharma A/S in Q3 2020 and has held it in 24 quarters since.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.